STOCK TITAN

Walgreen Boots SEC Filings

WBA NASDAQ

Welcome to our dedicated page for Walgreen Boots SEC filings (Ticker: WBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Struggling to spot prescription-margin shifts or opioid litigation charges buried inside Walgreens Boots Alliance’s lengthy reports? The company’s global mix of U.S. pharmacy retail, Boots UK, and Alliance Healthcare distribution makes every disclosure dense and data-heavy. Stock Titan’s AI decodes each page so you don’t have to.

Open a Walgreens Boots Alliance annual report 10-K simplified and our platform pinpoints script volume trends, reimbursement rate changes, and segment profitability in seconds. Need the latest Walgreens Boots Alliance quarterly earnings report 10-Q filing? Real-time feeds pull highlights on store closures, vaccination revenue, and Village Medical partnerships as soon as they hit EDGAR.

For governance questions, the Walgreens Boots Alliance proxy statement executive compensation tab shows how pay ties to prescription growth, while Walgreens Boots Alliance insider trading Form 4 transactions reveal whether pharmacists-turned-executives are buying or selling stock. Every Walgreens Boots Alliance Form 4 insider transactions real-time alert includes AI commentary on transaction size and timing.

  • AI-powered summaries translate complex accounting notes into clear language, making understanding Walgreens Boots Alliance SEC documents with AI effortless.
  • All filings, always current—from sudden Walgreens Boots Alliance 8-K material events explained to shelf registrations and S-8 plans.
  • Practical tools to compare quarter-over-quarter script counts, monitor cash flow swings, and flag opioid settlement reserves.

Whether you’re running an Walgreens Boots Alliance earnings report filing analysis before the bell or scanning a Walgreens Boots Alliance SEC filings explained simply overview, Stock Titan streamlines the entire research workflow. Receive alerts, read expert context, and make confident decisions—all from one page.

Rhea-AI Summary

Timothy C. Wentworth, an officer and Chief Executive Officer-level reporting person of Walgreens Boots Alliance, Inc. (WBA), reported a change in beneficial ownership dated 08/28/2025. The Form 4 shows Disposition of 1,332,014 shares of Common Stock, which the filing explains includes shares underlying restricted stock units (RSUs), inclusive of RSUs issued in lieu of dividends. The transaction arose from the Merger described in the Merger Agreement dated March 6, 2025, under which each share of Common Stock was converted at the effective time into $11.45 in cash plus one divested asset proceed right or an equivalent issued by the buyer. The RSUs were cancelled in exchange for that per-share consideration, and any unvested RSU consideration remains subject to the reporting person’s continued service and original vesting conditions. Following the reported transaction, the filing reports 0 shares beneficially owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Walgreens Boots Alliance insider Todd Heckman, SVP, Global Controller and CAO, reported the automatic conversion and disposition of his 93,037 shares of Company common stock in connection with the merger described in the filing. Under the Merger Agreement dated March 6, 2025, each share was converted at the effective time into $11.45 in cash plus one divested asset proceed right. The filing states Heckman's restricted stock units (including dividend-equivalent RSUs) were cancelled and exchanged for the same per-share consideration, but payment for any unvested RSUs remains subject to continued employment and the prior vesting conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Mary Langowski, EVP and President U.S. Healthcare of Walgreens Boots Alliance (WBA), reported a Section 16 transaction tied to the company's merger. On 08/28/2025 she is shown as disposing of 494,295 shares (including shares underlying restricted stock units), leaving her with zero shares of WBA following the transaction. The filing explains that under the Merger Agreement each share of common stock was converted into $11.45 in cash plus one divested asset proceed right. RSUs were cancelled in exchange for that per-share consideration, though amounts attributable to unvested RSUs remain subject to the reporting person's continued employment consistent with prior vesting conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Elizabeth Burger, Executive Vice President and Global Chief HR Officer of Walgreens Boots Alliance (WBA), reported a single Form 4 transaction dated 08/28/2025 showing the disposition of 303,875 shares of common stock. The filings explain these shares (including RSU-settled shares) were cancelled at the effective time of a merger and, per the merger agreement, converted into $11.45 per share in cash plus one divested asset proceed right per share. Unvested RSUs remain subject to original vesting and the holder's continued service. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Burger.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tracey D. Brown, Executive Vice President and President, Walgreens Retail, filed a Form 4 reporting disposition of company common stock and related RSUs in connection with the Merger. On 08/28/2025 the reporting person disposed of 348,051 shares (including shares underlying restricted stock units), and as a result reports 0 shares beneficially owned following the transaction. Under the Merger Agreement, each share of Common Stock was converted into $11.45 in cash per share plus one divested asset proceed right, and each RSU was cancelled in exchange for the same per-share consideration. Payment for any RSUs that were unvested at the Effective Time remains subject to the reporting person’s continued employment and the prior vesting conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Richard P. Gates, Senior Vice President and Chief Pharmacy Officer of Walgreens Boots Alliance (WBA), reported a transaction on 08/28/2025 disposing of 145,444 shares of Common Stock, leaving him with 0 shares beneficially owned following the reported transaction. The disposition reflects the treatment of restricted stock units (RSUs) at the closing of a merger: under the Merger Agreement dated March 6, 2025, each share of Common Stock was converted into $11.45 in cash plus one divested asset proceed right issued by the acquiror. RSUs were cancelled in exchange for that per-share consideration, with payment for any unvested RSUs conditioned on the recipient's continued service consistent with prior vesting terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ornella Barra, Chief Operating Officer, International of Walgreens Boots Alliance (WBA), reported material dispositions and cancellations tied to the company's merger closing on August 28, 2025. The merger converted each WBA share into $11.45 in cash plus one divested asset proceed right. The filing shows 969,057 shares disposed directly and 1,718,000 shares disposed indirectly through OLB Holdings Ltd., which the reporting person owns. It also states 525,167 shares represented by RSUs were part of the conversion into contingent cash and divested-asset rights, subject to continued service and original vesting conditions. Multiple employee stock options with exercise prices above $11.45 were canceled for no consideration, and the Reporting Person's direct beneficial ownership following the transactions is reported as zero.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Stefano Pessina, Executive Chairman and 10% owner of Walgreens Boots Alliance (WBA), reported material dispositions and cancellations tied to a completed merger. At the merger effective time, 1,317,544 restricted stock units (RSUs) held directly and 145,621,079 shares held indirectly through ASP Cayman converted into merger consideration consisting of $11.45 per share in cash plus a divested asset proceed right, subject to continued service vesting conditions. Multiple employee stock options with strikes of $57.38 to $82.46 were cancelled or disposed, and options with exercise prices equal to or above $11.45 were cancelled for no consideration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amendment No. 11 to the Schedule 13D reports that Alliance Sante Participations Ltd. (ASP Cayman) and Stefano Pessina completed a previously announced transaction under a Merger Agreement and, effective August 28, 2025, ceased to beneficially own any shares of Walgreens Boots Alliance, Inc. Common Stock.

As part of the closing, the Voting Agreement and Interim Investors Agreement were terminated and the transactions under the Reinvestment Agreement were completed. The cover pages reflect 0 shares and 0% ownership for both reporting persons.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Walgreen Boots (WBA)?

The current stock price of Walgreen Boots (WBA) is $11.98 as of August 29, 2025.

What is the market cap of Walgreen Boots (WBA)?

The market cap of Walgreen Boots (WBA) is approximately 10.4B.
Walgreen Boots

NASDAQ:WBA

WBA Rankings

WBA Stock Data

10.37B
710.98M
17.44%
60.94%
2.61%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DEERFIELD